Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

PRCT

PROCEPT BioRobotics (PRCT)

PROCEPT BioRobotics Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PRCT
FechaHoraFuenteTítuloSímboloCompañía
13/05/202415:05GlobeNewswire Inc.PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock ConferenceNASDAQ:PRCTPROCEPT BioRobotics Corporation
07/05/202420:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
06/05/202407:00GlobeNewswire Inc.Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic HyperplasiaNASDAQ:PRCTPROCEPT BioRobotics Corporation
03/05/202420:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRCTPROCEPT BioRobotics Corporation
01/05/202406:00GlobeNewswire Inc.PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue GuidanceNASDAQ:PRCTPROCEPT BioRobotics Corporation
29/04/202407:00GlobeNewswire Inc.Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic HyperplasiaNASDAQ:PRCTPROCEPT BioRobotics Corporation
23/04/202407:00GlobeNewswire Inc.PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual MeetingNASDAQ:PRCTPROCEPT BioRobotics Corporation
04/04/202415:04GlobeNewswire Inc.PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, TexasNASDAQ:PRCTPROCEPT BioRobotics Corporation
02/04/202415:03GlobeNewswire Inc.PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024NASDAQ:PRCTPROCEPT BioRobotics Corporation
27/02/202415:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRCTPROCEPT BioRobotics Corporation
27/02/202415:02GlobeNewswire Inc.PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:PRCTPROCEPT BioRobotics Corporation
12/02/202415:05GlobeNewswire Inc.PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in BostonNASDAQ:PRCTPROCEPT BioRobotics Corporation
08/02/202416:30GlobeNewswire Inc.CTS Corporation Announces Appointment of Amy M. Dodrill to its Board of DirectorsNASDAQ:PRCTPROCEPT BioRobotics Corporation
08/01/202416:00GlobeNewswire Inc.PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 millionNASDAQ:PRCTPROCEPT BioRobotics Corporation
08/12/202319:01Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:PRCTPROCEPT BioRobotics Corporation
13/11/202315:03GlobeNewswire Inc.PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York CityNASDAQ:PRCTPROCEPT BioRobotics Corporation
02/11/202315:40Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRCTPROCEPT BioRobotics Corporation
01/11/202315:02GlobeNewswire Inc.PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue GuidanceNASDAQ:PRCTPROCEPT BioRobotics Corporation
16/10/202315:05GlobeNewswire Inc.PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023NASDAQ:PRCTPROCEPT BioRobotics Corporation
12/10/202307:00GlobeNewswire Inc.The National Institute for Health and Care Excellence Endorses Aquablation® Therapy with "Standard Arrangements" RecommendationNASDAQ:PRCTPROCEPT BioRobotics Corporation
20/09/202307:00GlobeNewswire Inc.PROCEPT BioRobotics Announces New Corporate Headquarters in San JoseNASDAQ:PRCTPROCEPT BioRobotics Corporation
12/09/202307:00GlobeNewswire Inc.PROCEPT BioRobotics® Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate CancerNASDAQ:PRCTPROCEPT BioRobotics Corporation
22/08/202307:00GlobeNewswire Inc.PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in JapanNASDAQ:PRCTPROCEPT BioRobotics Corporation
17/08/202315:05GlobeNewswire Inc.PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in BostonNASDAQ:PRCTPROCEPT BioRobotics Corporation
16/08/202307:00GlobeNewswire Inc.NorthShore University HealthSystem offers expanded access to treat most common prostate ailmentNASDAQ:PRCTPROCEPT BioRobotics Corporation
03/08/202315:01Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRCTPROCEPT BioRobotics Corporation
01/08/202321:10GlobeNewswire Inc.PROCEPT BioRobotics Corporation Announces Pricing of Upsized Offering of Common StockNASDAQ:PRCTPROCEPT BioRobotics Corporation
01/08/202315:06GlobeNewswire Inc.PROCEPT BioRobotics Corporation Announces Proposed Offering of Common StockNASDAQ:PRCTPROCEPT BioRobotics Corporation
01/08/202315:01Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:PRCTPROCEPT BioRobotics Corporation
27/07/202306:00GlobeNewswire Inc.PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue GuidanceNASDAQ:PRCTPROCEPT BioRobotics Corporation
 Showing the most relevant articles for your search:NASDAQ:PRCT